PRAXIS PRECISION MEDICINES

praxis-precision-medicines-logo

Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance. Praxis is applying insights from genetic epilepsies to broader neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain.

#SimilarOrganizations #People #Financial #Website #More

PRAXIS PRECISION MEDICINES

Social Links:

Industry:
Alternative Medicine Biotechnology Health Care Medical Precision Medicine

Founded:
2015-09-22

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.praxismedicines.com

Total Employee:
51+

Status:
Active

Contact:
(617)949-2220

Total Funding:
573.12 M USD

Technology used in webpage:
HSTS DNSSEC Content Delivery Network Amazon LetsEncrypt DoubleClick.Net ReCAPTCHA JsDelivr Cloudflare JS Amazon Virginia Region


Similar Organizations

aro-biotherapeutics-logo

Aro Biotherapeutics

Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.

cabaletta-bio-logo

Cabaletta Bio

Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

coriell-life-sciences-logo

Coriell Life Sciences

Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

interline-therapeutics-logo

Interline Therapeutics

Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.

thrive-earlier-detection-logo

Thrive Earlier Detection

Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.


Current Advisors List

alfred-w-sandrock-jr_image

Alfred W. Sandrock Jr. Board Member @ Praxis Precision Medicines
Board_member

william-young_image

William Young Board Member @ Praxis Precision Medicines
Board_member

Current Employees Featured

alex-nemiroff_image

Alex Nemiroff
Alex Nemiroff General Counsel @ Praxis Precision Medicines
General Counsel
2020-06-01

megan-sniecinski_image

Megan Sniecinski
Megan Sniecinski Chief Business Officer @ Praxis Precision Medicines
Chief Business Officer
2021-12-01

marcio-souza_image

Marcio Souza
Marcio Souza President and CEO @ Praxis Precision Medicines
President and CEO
2020-04-01

david-goldstein_image

David Goldstein
David Goldstein Founder @ Praxis Precision Medicines
Founder
2019-01-01

lisa-huang_image

Lisa Huang
Lisa Huang Director of Corporate Development @ Praxis Precision Medicines
Director of Corporate Development

kelly-mccue_image

Kelly McCue
Kelly McCue Chief People Officer @ Praxis Precision Medicines
Chief People Officer
2021-01-01

alyssa-wyant_image

Alyssa Wyant
Alyssa Wyant Chief Regulatory and Quality Officer @ Praxis Precision Medicines
Chief Regulatory and Quality Officer
2021-12-01

elliot-ehrich_image

Elliot Ehrich
Elliot Ehrich Scientific and Clinical Advisory Board Member @ Praxis Precision Medicines
Scientific and Clinical Advisory Board Member
2018-11-01

nicholas-galakatos_image

Nicholas Galakatos
Nicholas Galakatos Director @ Praxis Precision Medicines
Director

steven-petrou_image

Steven Petrou
Steven Petrou Co-Founder, Chief Scientific Officer @ Praxis Precision Medicines
Co-Founder, Chief Scientific Officer
2022-04-01

Founder


david-goldstein_image

David Goldstein

kiran-reddy_image

Kiran Reddy

steven-petrou_image

Steven Petrou

Stock Details


Company's stock symbol is NASDAQ:PRAX

Investors List

ocv_image

OCV

OCV investment in Series C - Praxis Precision Medicines

eventide-asset-management_image

Eventide

Eventide investment in Series C - Praxis Precision Medicines

irving-investors_image

Irving Investors

Irving Investors investment in Series C - Praxis Precision Medicines

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series C - Praxis Precision Medicines

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series C - Praxis Precision Medicines

avoro-capital-advisors_image

Avoro Capital Advisors

Avoro Capital Advisors investment in Series C - Praxis Precision Medicines

blackstone-life-science_image

Blackstone Life Sciences

Blackstone Life Sciences investment in Series C - Praxis Precision Medicines

point72-ventures_image

Point72 Ventures

Point72 Ventures investment in Series C - Praxis Precision Medicines

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Series C - Praxis Precision Medicines

qatar-investment-authority_image

Qatar Investment Authority

Qatar Investment Authority investment in Series C - Praxis Precision Medicines

Official Site Inspections

http://www.praxismedicines.com Semrush global rank: 2.22 M Semrush visits lastest month: 9.44 K

  • Host name: 172.67.215.221
  • IP address: 172.67.215.221
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Praxis Precision Medicines"

Praxis Precision Medicines, Inc. Management Team | Org Chart

Praxis Precision Medicines, Inc. employs 134 employees. The Praxis Precision Medicines, Inc. management team includes Marcio Souza (President and CEO), Kelly McCue (Chief People …See details»

FAQs - Praxis Precision Medicines, Inc. - ir.praxismedicines.com

Oct 16, 2020 ComputerShare Trust Company, N.A. 462 South 4th Street, Suite 1600 Louisville, KY 40202 For help with change of address, transfer of shares, loss of share certificates, …See details»

Praxis Precision Medicines, Inc. Company Overview, Contact …

Mar 28, 2024 Praxis Precision Medicines, Inc. Biotechnology Research Massachusetts, United States 51-200 Employees. Praxis Precision Medicines is a clinical-stage biopharmaceutical …See details»

Praxis Precision Medicines to Present at Two February Investor ...

Feb 3, 2025 For more information, please visit www.praxismedicines.com and follow us on Facebook, LinkedIn and Twitter/X. Investor Contact: Praxis Precision Medicines …See details»

Praxis Precision Medicines, Inc. | LinkedIn

Praxis Precision Medicines, Inc. | 11,172 followers on LinkedIn. The era of genetic neuroscience has arrived | Praxis Precision Medicines is a clinical-stage biopharmaceutical company …See details»

Praxis Precision Medicines - Crunchbase Company Profile & Funding

Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) …See details»

Press Release - Praxis Precision Medicines, Inc.

Mar 31, 2022 Investor Contact: Alex Kane Praxis Precision Medicines investors@praxismedicines.com 617-300-8481 Media Contact: Ian Stone Canale …See details»

Praxis Precision Medicines, Inc. (PRAX) Company Profile & Overview

Oct 16, 2020 Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized …See details»

Praxis Precision Medicines (USA) Funding: $573.1M

Feb 20, 2025 Praxis is a clinical-stage genetic neuroscience company that develops high-impact therapies for patients and families affected by complex and debilitating brain...See details»

Press Release - Praxis Precision Medicines, Inc.

Nov 28, 2023 Investor Contact: Praxis Precision Medicines investors@praxismedicines.com 857-702-9452 Media Contact: Ian Stone Canale Communications …See details»

Praxis Precision Medicines - businessabc.net

6 days ago Praxis Precision Medicines was founded in 2013. Since then, the company has advanced its platform for discovering, developing and commercializing treatments for genetic …See details»

Praxis Precision Medicines - Datanyze

Www.praxismedicines.com Praxis Precision Medicines Profile and History Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the …See details»

Praxis Precision Medicines - Overview, News & Similar ... - ZoomInfo

May 13, 2024 Praxis Precision Medicines contact info: Phone number: (617) 300-8460 Website: www.praxismedicines.com What does Praxis Precision Medicines do? Praxis Precision …See details»

Press Release - Praxis Precision Medicines, Inc.

May 10, 2024 For more information, please visit www.praxismedicines.com and follow us on Facebook, LinkedIn and Twitter/X. Investor Contact: Praxis Precision Medicines …See details»

Press Release - investors.praxismedicines.com

For more information, please visit www.praxismedicines.com and follow us on Facebook, LinkedIn and Twitter/X. Investor Contact: Praxis Precision Medicines investors@praxismedicines.com …See details»

Praxis Precision Medicines Announces Closing of Financing and ...

Jun 22, 2023 For more information, please visit www.praxismedicines.com and follow us on Facebook, LinkedIn and Twitter. Forward-Looking Statements This press release contains …See details»

Praxis Precision Medicines, Inc. (Praxis Precision Medicines, Inc ...

The Piper Sandler live webcast will also be available through the “Upcoming & Recent Events” page of the Investors + Media section of the company’s website at www.praxismedicines.com. …See details»

Praxis Precision Medicines Provides Update on Essential3

1 day ago PRAXIS PRECISION MEDICINES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Amounts in thousands) (Unaudited) December 31, 2024 December 31, 2023See details»

Praxis Precision Medicines to Host PRAX-628 Program Update

Mar 25, 2024 For more information, please visit www.praxismedicines.com and follow us on Facebook, LinkedIn and Twitter/X. Investor Contact: Praxis Precision Medicines …See details»

Praxis Precision Medicines to highlight their Epilepsy Portfolio at …

Sep 4, 2024 For more information, please visit www.praxismedicines.com and follow us on Facebook, Instagram, LinkedIn and Twitter/X. Investor Contact: Praxis Precision Medicines …See details»

linkstock.net © 2022. All rights reserved